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ABSTRACT 
 
Different Chlorhexidine (CHX) preparations and formulations are available in local markets. 
Some preparations contain Anti-discoloration systems (ADS), additional antimicrobials like 
Cetylpyridinium chloride (CPC), or alcohol. The aim of this study was to compare the 
antimicrobial efficacies of 3 different CHX preparations (Corsodyl®, Curasept® and GUM
® 
Paroex®). 
Methods: 
A disk diffusion test was performed using pure cultures of the organisms Streptococcus 
mutans and Candida albicans, in addition to mixed cultures (facultative and strict anaerobes) 
prepared from 14 study participants’ oral rinse samples. The means and standard deviations 
of the diameters of inhibition zones were calculated for the different culture types. 
Results: 
ANOVA test was used to verify whether the differences in means were statistically 
significant. Accordingly, a statistically significant difference (p. value = 0.0001) was found 
only in Candida albicans cultures between the mean inhibition zones of the different CHX 
preparation disks. Pure CHX preparations and Corsodyl® proved to be of higher antifungal 
efficacy than Curasept® and Paroex®. 
Conclusion: 
Within the limitations of the study, it can be concluded that both pure and alcohol containing 
CHX preparations (Corsodyl®) are more potent against C.albicans than alcohol-free CHX 
preparations (Curasept® and Paroex®). However, in mixed cultures (facultative and strict 
anaerobes), alcohol-free CHX preparations (Curasept® and Paroex®) have antimicrobial 
efficacies comparable to that of both alcohol-containing (Corsodyl®) and pure CHX 
formulations (0.2% and 0.12%). 
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CHAPTER 1 
INTRODUCTION 
 
 
Chlorhexidine (CHX) has been the gold standard for evaluating new chemical plaque control 
agents (Jones, 1997). In this study, three locally available CHX products in South Africa 
were tested in vitro against two preparations of pure CHX, to compare their antimicrobial 
effects on:    
1) Facultatively anaerobic cultures prepared from oral rinse samples.  
2) Strictly anaerobic cultures prepared from the same oral rinse samples.  
3) Pure cultures of S. mutans prepared from the laboratory. 
4) Pure cultures of C. Albicans prepared from the laboratory. 
Commercially available CHX formulations differ in their concentrations as well as in the 
component additives present. Most CHX oral rinses are prepared in two concentrations: 0.2% 
and 0.12%. Some CHX preparations have alcohol added in concentrations as high as 14-15%, 
while others are alcohol free, the addition of which is controversial because of its 
carcinogenic potential and tissue irritating properties (Herrera et al., 2003).  
Some CHX preparations contain additional antimicrobials, like Cetylpyridinium chloride 
(Sreenivasan et al., 2012). Others have chemicals added to prevent teeth discolouration; a 
common side effect with prolonged use of CHX. It has been suggested that alterations to 
CHX formulations may have an effect on its antimicrobial efficacy (Herrera et al., 2003).  
Previous studies examining different CHX preparations have shown a lack of consensus 
regarding the effect of additives on the antimicrobial efficacies of the different preparations 
(Guggenheim and Meier, 2011, Arweiler et al., 2006 & Herrera et al., 2003). This makes it 
imperative to test any CHX formulation that contains additives against well-studied and 
documented CHX formula.     
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Chlorhexidine: 
Dental plaque is the primary aetiological factor implicated in dental caries and periodontal 
disease. It is a biofilm of different bacterial species protected by an extracellular 
polysaccharide matrix, which enables it to adhere to tooth and soft tissue surfaces. Early in 
plaque formation, the prominent organisms are Gram positive aerobic bacteria, collectively 
referred to as the primary colonizers. As the biofilm matures, more Gram negative facultative 
anaerobes and obligatory anaerobes, including spirochetes, accumulate. These bacteria are 
secondary colonizers. This matures further and becomes a complex ecosystem and affords 
biological advantages to all the organisms involved. It facilitates the exchange of nutrients 
and waste products. It also resists the diffusion of antimicrobials and other harmful, potent 
microbicidals into the biofilm (Marsh et al., 2011). 
The first scientifically proven study demonstrating the effect of chlorhexidine on dental 
plaque microbes was performed in 1970 by Loë and Schiott. They showed that rinsing the 
mouth with 10 ml of 0.2% chlorhexidine for 60 seconds twice a day for 10 days, in the 
absence of mechanical plaque control, prevented the build-up of dental plaque and the 
subsequent development of gingivitis (Loë and Schiott, 1970). 
The antibacterial effect of CHX has a wide spectrum. It is effective against both Gram 
positive and Gram negative organisms, but with different susceptibilities (expressed as 
different minimum inhibitory concentrations - MIC). Species with low MIC include 
Staphylococci, S. mutans, S. salivarius and E. coli, while the most resistant strains are Gram-
negative cocci such as Veillonella (Emilson, 1977). 
CHX is active not only against bacterial plaque species, but also against fungi (Gomes et al., 
2013). Candida species form part of the normal microbial flora of the oral cavity in 15-75% 
of healthy individuals (Ten Cate et al., 2009). The ratio increases to 80% in geriatric patients 
wearing dentures (Vanden et al., 2008). C. albicans is by far the most common fungal species 
encountered in mycotic infections (Kraneveld et al., 2012). 
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2.1.1 Chemical Structure: 
By the end of the 1940s, British scientists were involved in developing potent antimalarial 
drugs. An English company, The Imperial Chemical Industries Limited, managed to 
synthesize a group of compounds known collectively as the polybiguanides that demonstrated 
a broad spectrum of antimicrobial activity (Lindhe et al., 2008). Further explorations of the 
chemical structure of the polybiguanides led in the 1950s to the synthesis of the 
bisbiguanides, which surpassed the original compounds by virtue of its wide antimicrobial 
spectrum. From that group of compounds, and through modifications to the chemical 
formulae at hand, it was possible to synthesize the compound with the highest bacteriostatic 
and bactericidal effects. That compound (1, 6, bis-4, chloro, phenyldiguanidohexane), 
became known as chlorhexidine, a very strong cationic compound (Davies et al., 1954). 
 
Figure-1: Chlorhexidine molecule: two symmetrical 4-chlorophenyl groups and two 
bisguanides groups linked by a hexamethylene bridge between them (Davies et al., 1954).  
2.1.2 Uses in Dentistry: 
When used prophylactically as an adjunct to mechanical debridement, CHX can reinforce the 
effects of mechanical plaque control by preventing adhesion and accumulation of dental 
plaque onto clean surfaces. It was found that warm mouthwashes were more efficacious than 
cold ones at reducing the oral microbial load (König et al., 2002). Due to the high 
susceptibility of S. mutans to CHX, it is commonly used to control dental caries in patients 
who prove to be in the high risk group (Gupta et al., 2012). 
Dental prosthetics and orthodontic appliances can retain dental plaque and hamper 
mechanical plaque control. Thus disinfecting complete or partial dentures by immersing them 
in 0.2 %chlorhexidine solution at night can decrease the incidence of denture stomatitis 
(Gupta et al., 2012). 
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Recently, the postoperative use of CHX mouth rinses has replaced periodontal packs as the 
standard periodontal surgical care used to enhance healing in an infection-free environment. 
Other periodontal applications of CHX include its adjunctive use in total mouth disinfection, 
and as a substitute for saline in cooling ultrasonic tips (Lindhe et al., 2008). 
Patients with inter-maxillary fixation and those who are mentally challenged will benefit 
from the antimicrobial effects of CHX as a substitute for and adjunct to mechanical plaque 
control (Gupta et al., 2012).  
The incidence and duration of minor aphthous ulcers are reportedly decreased following 
CHX use. This effect can be related to CHX’s ability to control superimposed secondary 
bacterial infections (Gupta et al., 2012).  
Other reported uses of CHX include using it as a root canal disinfectant, for the treatment of 
halitosis and as disinfectant prior to performing oral surgical procedures. Non-dental uses 
include its use in ocular infections (in form of eye drops) and as a bio-adhesive vaginal gel in 
the treatment of bacterial vaginitis (Gupta et al., 2012).       
2.1.3 Mechanism of Action: 
Bacterial cell membranes contain phosphate groups that render them negatively charged.  The 
strong positive charge of the CHX molecule is electrostatically attracted to negatively 
charged bacterial surfaces. This interaction damages the physical integrity of the bacterial cell 
membrane and results in leakage of cytoplasmic solutes, such as potassium. This effect is 
usually observed at low concentrations of CHX, and it is responsible for the bacteriostatic 
property of CHX. At higher concentrations, CHX precipitates cytoplasmic proteins and 
becomes microbicidal to organisms exposed to it (Mathur et al., 2011& Gomes et al., 2013). 
The actual concentrations at which the effect is bacteriostatic or bactericidal varies according 
to the bacterial species under investigations (Denton, 1991).  
The adherence of the positively charged CHX to the negatively charged hard and soft tissue 
surfaces also explains its ability to withstand the flushing effect of saliva and other fluids in 
the oral cavity, long after its application. This phenomenon, termed substantivity, ensures the 
slow, continual release of CHX from oral tissue surfaces that makes its effects last for several 
hours (Gomes et al., 2013).        
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Since CHX is a base, its aqueous solution is chemically more stable at pH ranges between 5 
and 8. Moreover, its antimicrobial activity is pH dependent. This activity is optimum between 
pH 5.5 and 7, which is similar to that of body fluids such as saliva (Gomes et al., 2013). 
2.1.4 Toxicity and side effects:  
Systemic absorption of CHX via the mucosa of the gastrointestinal tract is virtually non-
existent. This is due to the hydrophobic nature of the cationic CHX molecule (Gupta et al., 
2012). As a result, all side effects of CHX are local reactions. These include the brownish 
staining of the teeth and dorsum of the tongue encountered after relatively short use (10-15 
days) and taste disturbances, particularly salty taste (Lindhe et al., 2008). Epithelial 
desquamation can occur and in some patients, soft tissue lacerations have been reported after 
prolonged exposure. Parotid salivary gland swelling has only occasionally been reported. 
Lastly, CHX enhances supra-gingival calculus formation. This is attributed to its ability to 
precipitate salivary proteins, thereby accelerating pellicle formation. Used appropriately CHX 
is generally considered to be safe (Gupta et al., 2012). 
2.1.5 In-vitro studies demonstrating decreased antimicrobial efficacy of 
different CHX preparations in the presence of non-alcoholic additives: 
Several In vitro studies evaluated the antimicrobial effects of commercially available 
mouthrinses containing CHX. A Swiss study (Guggenheim and Meier, 2011) compared 
different CHX mouth washes with and without Anti Discolouration Systems (ADS) to 
Listerine® (Table 1). Water and pure CHX -in the form of an aqueous solution of 0.15% 
concentration- were used as negative and positive controls respectively.  The results showed 
that the antimicrobial effects of Curasept® (non-alcohol CHX 0.12% with ADS), and 
Parodentosan® (CHX 0.05% with 15% alcohol) were 10,000 times weaker than PlakOut® 
rinse solution (CHX 0.1% with 8% alcohol), PlakOut® liquid (CHX 0.2% with 45% alcohol) 
and the positive control (pure CHX 0.15%). According to this study, both CHX formulations 
with chemical additives in the form of ADS i.e. the alcohol containing Parodentosan®  and 
the alcohol free Curasept®, exhibited a lower antimicrobial efficacy than CHX formulations 
without ADS (PlakOut®) and pure CHX. It was concluded that “it is not possible to 
formulate CHX mouthwash preparations that have effective anti-discolouration systems 
without negatively affecting its antimicrobial efficacy” (Guggenheim and Meier, 2011). 
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Another study (Herrera et al., 2003) compared the antimicrobial effects of different CHX 
products with and without alcohol. Preparations used included PerioAid® (CHX 0.12% with 
5% alcohol), PerioAid® Sin Alcohol® (non-alcohol CHX 0.12% with 0.05% CPC), Cariax 
Gingival® (non-alcohol CHX 0.12% with Sodium NaF) and Chlorhexidina Lacer® (non-
alcohol CHX 0.12%) (Table 1). The study concluded that CHX preparations that contained 
alcohol showed enhanced antimicrobial activity in vitro, however the possibility of other 
additives imparting an antimicrobial effect could not be entirely excluded (Herrera et al., 
2003).   
2.2 Anti-Discolouration System: 
ADS is a term used to encompass a number of chemical compounds used collectively to 
prevent the brown discolouration encountered with prolonged use of CHX (Bernardi et al., 
2004). They are added to various products with different active ingredients. Prominent ADS 
compounds include ascorbic acid and sodium sulphite (Cortellini et al., 2008).  
2.3 Cetylpyridinium Chloride: 
Cetylpyridinium Chloride is a quaternary ammonium compound with a strong cationic nature 
that is readily attracted to negatively charged surfaces (Cortesia et al., 2010). CPC is typically 
active against Gram positive bacteria and fungi, with demonstrable bactericidal effects (Liu et 
al., 2013). The FDA classifies CPC amongst the safest and most effective chemical agents 
(class I for safety, and class I for efficacy) when used as a disinfectant in concentrations 
ranging from 0.045% - 0.10% (Sreenivasan et al., 2012). Most CPC formulations have 0.05% 
concentration.  However, its efficacy was found to be affected by the presence of other 
chemicals that are commonly added to the formula as excipients such as ethanol, sorbitol, 
glycerine, propylene glycol and monosodium phosphate (Fathilah et al., 2012). A 
commercially available mouthwash, Paroex® contains 0.05 % CPC. 
2.4 Alcohol:  
Some authors are of the opinion that the addition of alcohol to CHX solutions is necessary for 
chemical stability, improved antimicrobial efficacy and to prevent its contamination (Vigeant 
et al., 1998). The argument against adding alcohol is threefold: 1) the well-known 
carcinogenic potential of ethanol (Elmore and Horwitz, 1995). In alcoholics, the use of 
alcohol containing mouthwashes increases the risk of developing oropharyngeal cancer 
(Winn et al., 1991). 2) the tissue irritating properties, which precludes its use in radiation or 
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chemotherapy damaged epithelial surfaces (Ennibi et al., 2013). In patients under 
chemotherapy or radiation therapy, symptoms of mucositis -if present- will be aggravated; 
and 3) Alcohol allergy (Eldridge et al., 1998). Alcohol is known as an allergen that can 
induce hypersensitivity reactions in susceptible individuals (Rajan and Khan, 2010). 
2.5 Streptococcus mutans:  
S. mutans is the most cariogenic intra-oral bacteria (Mai et al., 2011). The Gram positive, 
facultatively anaerobic coccus is one of the primary colonizers in plaque formation (Lindhe et 
al., 2008). The organism adheres to the salivary proteins, epithelial cells and 
polymorphonuclear cells covering tooth surfaces –i.e. the dental pellicle- shortly after its 
formation. Dental plaque samples taken 24 hours after mechanical cleaning consists mostly 
of Streptococci (Lindhe et al., 2008).    
2.6 Candida albicans:  
More than 150 species are found in the Candida genus. Strains of Candida are part of the 
normal oral flora in healthy individuals. Candida albicans is an opportunistic pathogen that 
frequently affects medically compromised individuals, and denture wearers (Pereira-Cencip 
et al., 2008).The fungus is dimorphic, i.e. it can exist in either a yeast or hyphal form, 
depending on the environmental conditions (Farah et al., 2010). The clinical variants of oral 
candidiasis includes: acute pseudomembranous, chronic atrophic, chronic erythematous 
(including angular cheilitis and denture stomatitis) or chronic hyperplastic candidiasis 
(Williams and Lewis, 2011).  
2.7 Facultative anaerobes:  
These organisms can grow in the presence or absence of oxygen and develop during the early 
phases of dental plaque formation. Beside Streptococci, Actinomyces species are among the 
major primary colonizers that consume oxygen, thereby paving the way for strictly anaerobic 
secondary colonizers (Marsh et al., 2011).  These Gram positive rods are initially found in 
low numbers, gradually increasing to eventually outnumber streptococci (Lindhe et al., 
2008). 
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2.8 Strict anaerobes:  
They cannot grow in the presence of oxygen and are secondary colonizers in dental plaque. 
They are mostly Gram negative rods and are strict anaerobes, such as Porphyromonas 
gingivalis and Tannerella forsythia (Marsh et al., 2011). These organisms possess an array of 
proteolytic enzymes and other virulence factors that define them as the major periopathogens 
(Lindhe et al., 2008)   
Table 1: CHX products tested in previous studies. 
Study Product & Manufacturer Active 
Ingredients 
Additives 
Guggenheim & 
Meier, 2011 
PlakOut®, (KerrHawe SA, 
Bioggio) 
CHX digluconate 
0.1% 
Ethanol 8% v/v, flavouring, dye: 
E127 
 PlakOut®, (KerrHawe SA, 
Bioggio) 
CHX digluconate 
0.2% 
Ethanol 45 vol.%, flavouring 
 Curasept® (Curaden Health-
Care, Saronno (VA), Italy) 
CHX digluconate 
0.12% 
Xylitol, propylene glycol, PEG 
40, hyd. castor oil, ascorbic acid, 
Poloxamer 407, sodium 
metabisulfite sodium citrate, 
aroma Cl.42090 
 Curasept® (Curaden Health-
Care, Saronno (VA), Italy) 
CHX digluconate 
0.2% 
Xylitol, propylene glycol, PEG 
40, hyd. castor oil, ascorbic acid, 
Poloxamer 407, sodium 
metabisulfite sodium citrate, 
aroma Cl.42090 
 Parodentosan® (Tentan AG, 
Ramlinsburg) 
CHX digluconate 
0.05% 
Per ml: Ethanol 15 vol.%, myrrh 
tincture 1.9 mg, sage oil 0.5 mg, 
peppermint oil 0.08 mg, 
xylitol and other adjuvants 
 Listerine® (Johnson & Johnson, 
Maidenhead UK) 
Thymol 0.064%,  
Menthol 0.042%  
Eucalyptol 0.060% 
Ethanol 21%, Sorbitol, 1-
propanol, methylsalicylate, 
Poloxamer 407, benzoic acid Cl 
l47005, sodium fluoride 100 ppm, 
and others 
 Pure CHX (Sigma-Aldrich, 
ChemieGmbh, D-Steinheim 
88552) – Positive Control 
CHX digluconate 
0.15% 
 
 Water – Negative Control   
Herrera et al., 
2003 
PerioAid® (Dentaid, Spain) CHX 0.12%  Ethanol 5% 
 PerioAid Sin Alcohol® 
(Dentaid, Spain)  
CXH 0.12%  0.05% Cetylpyridinium Chloride 
 Cariax Gingival® (Kin SA, 
Spain) 
CHX 0.12% 0.05% Cetylpyridinium Chloride 
 Chlorhexidina Lacer® (Lacer 
SA, Spain) 
CHX 0.12%  
 
 
 
 
 
 
9 
 
CHAPTER 3 
Aim and Objectives 
 
3.1 Aim: 
To compare the antimicrobial efficacy of three locally available CHX mouth rinses. 
3.2 Objectives: 
To measure the antimicrobial efficacy of: 
1.  Curasept®: an alcohol free, 0.2% CHX gluconate, with ADS in the form of chemical 
additives. 
2- Paroex®: an alcohol free, 0.12% CHX gluconate with 0.05% CPC. 
3- Corsodyl®: 0.2% CHX gluconate with 5% alcohol. 
            Against 1) Streptococcus mutans, 2) Candida albicans, 3) Facultative anaerobes and 
4) Strict anaerobes 
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CHAPTER 4 
METHODOLOGY 
 
4.1 Study design:  
This study was an in vitro analytical study of an exploratory nature. 
4.2 Study sample: 
All staff members at the University of the Western Cape, Dental Faculty were invited to 
participate in the study. Every alternate staff member who presented between 2:00pm and 
4:00 pm on 2 consecutive Mondays, were selected to participate. Oral rinse samples were 
collected from 14 staff members, who met the inclusion criteria.     
4.2.1 Inclusion criteria: 
1- Dentate and partially dentate individuals.  
2- Persons above 12 years of age. 
3- Systemically healthy. 
4.2.2 Exclusion criteria: 
1- Edentulous individuals. 
2- Children below 12 years old. 
3- Patients with systemic conditions. 
4- Smokers. 
5- Individuals who have used antibiotics or immunosuppressive drug therapies 
during the past 3 months. 
6- Persons with active periodontal disease. 
7- Persons with active carious lesions. 
8- Persons with oral candidiasis. 
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4.3 Materials 
4.3.1 The CHX preparations: 
The 3 commercially available mouthrinses were purchased from local stores, while the 
controls - (pure CHX preparations) - were obtained from the Institute of Oral and Dental 
Research at the Faculty of Dentistry, University of the Western Cape. These particular CHX 
formulations were chosen because –to the best of the author’s knowledge- they were the most 
commonly found in local markets in Cape Town, South Africa. 
 
Figure 2: The 3 commercial CHX products; Corsodyl® (CHX3), Curasept® (CHX4) and 
Paroex® (CHX5)  
The pure CHX formulation was in the form of an aqueous (water based) solution of 20% 
CHX concentration.  Two different concentrations (0.2% & 0.12%) of alcohol-free pure CHX 
were prepared by titration with sterile water. The pure CHX 0.2% acted as a control for 
Corsodyl® and Curasept® (both having CHX 0.2% concentration), while pure CHX 0.12% 
was the control for Paroex® (CHX 0.12%). 
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Table 2: CHX products tested in the current study. 
CHX1-CHX5: codes as used in the disk diffusion test 
CHX preparation Active ingredients 
20% aqueous solution CHX digluconate  
(Sigma-Aldrich) – CHX1 
CHX 0.2% 
20% aqueous solution CHX digluconate  
(Sigma-Aldrich) – CHX2 
CHX 0.12% 
Corsodyl® - CHX3 CHX 0.2%, Ethanol 5% 
Curasept® - CHX4 CHX 0.2%, ADS (Xylitol, propylene glycol, 
PEG 40, hyd. castor oil, ascorbic acid, 
Poloxamer 407, sodium metabisulfite sodium 
citrate, aroma Cl.42090) 
Paroex® - CHX5 CHX 0.12%, Cetylpyridinium Chloride 
0.05%  
 
4.3.2 Digital calliper 
A commercially available digital calliper was purchased. Readings were adjusted to two 
decimal places, and measuring units were centimetres.  
 
Figure 3: Digital calliper used to measure dimensions of inhibition zones 
4.4 Ethical approval 
Ethical approval was obtained from the UWC Dental Faculty. Individual participant consent 
for specimen collection was via informed consent. The voluntary nature of the participation 
in this study was clearly explained to the participants, along with any potential advantage, 
disadvantage, compensation or complaints that might result due to taking part in this study.  
The researcher's contact details were available to all participants for further information about 
the study or its outcome. 
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4.5 Conflict of Interest 
This study was funded by the Faculty of Dentistry, University of the Western Cape. Neither 
financial nor any other kind of material support was offered by the manufacturers of the 
different products under investigation. The researcher thereby declares no conflict of interest 
in this study. Any relevant findings will be submitted for publications. 
4.6 Specimen preparation and data collection  
4.6.1 Collection and preparation of oral rinse samples 
Oral rinse samples were collected from 14 staff members at the faculty of Dentistry, UWC, 
who met the inclusion criteria. Each subject was supplied with 10 ml of sterile saline in a 
universal container and instructed to rinse the mouth meticulously in the presence of the 
researcher for 60 seconds and then return the mouth rinse to the container (Samaranayake et 
al., 1986). 
 
Figure 4: Universal containers each with 10ml of oral rinse solution collected from study 
participants – numbers on containers correspond to code numbers given to participants. 
100µl of the rinse was inoculated onto previously prepared Brain Heart Infusion agar plates, 
by spreading the sample over the agar surface with a sterile glass rod. For each oral rinse 
sample, two plates were prepared, one for facultative anaerobic cultures, and the other for 
strictly anaerobic cultures. The latter was done to culture Gram negative anaerobic bacteria, 
such as Veillonella and Fusobacteria (Dzink et al., 1985).  The anaerobic conditions were 
created inside an anaerobic jar utilizing an anaerobic system (Oxoid® Gas generating kit – 
made in UK), with Palladium as a catalyst. A colour indicator was used to signal the 
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transformation to anaerobic conditions. For the facultative anaerobic cultures, an anaerobic 
incubator was used. The incubation period for both types of cultures was 24 hours.    
4.6.2 Preparation of pure cultures 
Pure cultures of S. mutans and C. albicans were selected, as these microorganisms are known 
etiological factors for dental caries and candidiasis respectively.  To this end, S. mutans 
NCTC 25175 and C. albicans NCTC 36801 type strains were cultured in the laboratory 
overnight (24 hours). Thereafter, a separate inoculum from each culture was prepared. This 
was done by selecting appropriate cultures and preparing a suspension thereof in saline using 
the direct colony suspension method. 
The two suspensions (S. mutans & C. albicans) were standardized to 0.5 McFarland standard 
(corresponding approximately to 1.5 X 10
8
 CFU/ml). The McFarland scale is used for 
measuring bacterial densities in suspensions (Table 3). There was no need to standardize the 
turbidity of the oral rinse samples since its natural turbidity closely approximated that of the 
0.5 McFarland standard. 
Table 3: McFarland standards and corresponding cell counts. 
McFarland Standard Approximate Cell Count Density (x108cells) 
0.5 1.5 
1.0 3.0 
2.0 6.0 
3.0 9.0 
4.0 12.0 
 
100µl of each suspension was inoculated onto 14 standard BHI plates within a quarter of an 
hour of the suspension preparation. Sterile glass-rods were used to spread the suspension 
evenly on the surface of the plate. This ensured a more or less balanced distribution of the 
bacteria in question throughout the surface of the 28 agar plates.  
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4.6.3 Disk Diffusion Test to measure inhibition zones 
The 56 agar plates used for the disk diffusion test were divided equally into 4 groups as listed 
below: 
(1) Group 1: 14 facultative anaerobically cultured plates prepared from oral rinse 
samples.  
(2) Group 2: 14 strict anaerobically cultured plates prepared from oral rinse samples. 
(3) Group 3: 14 plates of pure cultures of S. mutans bacteria. 
(4) Group 4: 14 plates of pure cultures of the fungus C. albicans. 
The disk diffusion test was performed by adding 5 sterile, 6mm diameter, filter paper disks to 
each of the 56 BHI plates. Each disk was saturated with 10µl of the specified CHX products 
tested and assigned a code number corresponding to the CHX product used (Figure 5). The 
disks were evenly distributed on the agar surface. The antibacterial effects of each CHX 
product was measured in terms of the dimensions of the bacterial growth inhibition zone 
around the disks that occurred within 24hours of incubation (Figure 6). 
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ORAL RINSE SAMPLES(n=14) 
          S. mutans(n=14)           C. albicans(n=14) 
Facultative 
Anaerobes         Strict anaerobes 
(n=14)          (n=14) 
 
 
 
                                                                             
 
Figure 5: Agar plates and filter paper disks used in disk diffusion test illustrating the 
inhibition zone. S. mutans and C.albican were inoculated from pure cultures. 
All measurements were executed by the principal investigator and a second clinician using a 
digital calliper (Figure 3). The diameter of each inhibition zone was measured three times, by 
each investigator, who was blinded to the preceding measurement. The readings were 
averaged and those with a discrepancy of more than 1mm were discarded and re-measured. 
Data capturing tables (Appendix 3), were used to record the readings, from which the mean 
and standard deviation were calculated. 
 
 
 
CHX1 
CHX2 CHX5 
CHX3 CHX4 
CHX1 CHX1 CHX1 
CHX5 CHX5 CHX5 
CHX4 CHX4 CHX4 CHX3 CHX3 CHX3 
CHX2 CHX2 CHX2 
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Figure 6: BHI agar plates no.5 - (out of 14 for each) - showing S.mutans and C.albicans pure 
cultures with inhibition zones around different CHX preparations. Numbers on filter papers 
denotes the following: - 1: CHX1 (Pure CHX 0.2%), 2: CHX2 (Pure CHX 0.12%), 3: CHX3 
(Corsodyl®), 4: CHX4 (Curasept®) and 5: CHX5 (Paroex®) 
 
4.7 Data Analysis: 
The mean diameters of the corresponding inhibition zones and standard deviation were 
calculated and compared using the analysis of variance (ANOVA) test. A p value of less than 
0.05% was considered statistically significant. 
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CHAPTER 5 
RESULTS 
 
5.1 Demographic characteristics of participants: 
All of the 14 volunteers participating in the study were staff members of UWC Dental 
Faculty. The majority of the participants were females (71.43%), with males only making up 
28.57% of the sample. The age range for the study participants was 19-68 years, with a mean 
age of 38 years (standard deviation =16.84). 
5.2 Means of inhibition zones’ diameters: 
The mean inhibition zone for each CHX disk per agar plate was calculated from the 3 
measurements recorded. A second mean (group mean) was calculated from the average of all 
14 disks impregnated with the same CHX preparation. 
     Table 4: Group means and Standard Deviations for inhibition zones (in cm) 
n=14 pure CHX 0.2% pure CHX 0.12% Corsodyl® Curasept® Paroex® 
S.mutans 
 
2.48± 0.37 2.31± 0.47 2.39± 0.44 2.15± 0.39 2.10± 0.32 
C.albicans 1.30± 0.09 1.25± 0.11 1.29± 0.11 1.06± 0.06 1.05± 0.10 
Facultative 
anaerobes 1.31± 0.36 1.28± 0.36 1.23± 0.34 1.20± 0.34 1.19± 0.34 
Strict 
anaerobes 1.34± 0.29 1.21± 0.29 1.29± 0.29 1.17± 0.27 1.13± 0.40 
 
Corsodyl® and Curasept® both comprise a 0.2% CHX concentration with additives; they 
were compared to a pure CHX formulation of the same concentration. Figure 7 compares 
their inhibition zones for the 4 culture types. 
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Figure 7: Different means of inhibition zones attained by the 3 different CHX 0.2% 
preparations for the 4 culture types. 
Curasept® produced the lowest readings in all types of culture, while Corsodyl® scored 
better readings than Curasept®, but still lower than the pure CHX 0.2% formulation. 
When Paroex® (CHX 0.12% + CPC 0.05%) was compared to pure CHX 0.12%, the 
following results were found (Figure 8).  
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Figure 8: Different means of inhibition zones attained by the 2 different CHX 0.12% 
preparations. 
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When the means of inhibition zones for all CHX formulations were considered together, 
readings could thus be represented as in Figure 9. 
 
Figure 9: Different means of inhibition zones attained by all CHX preparations. 
Figure 10 represents the performance of each CHX formulation across the 4 different types 
of cultures. Streptococcus mutans cultures were clearly more sensitive to all CHX 
formulations than other cultures, while Candida albicans cultures showed sensitivity 
comparable to that of facultative and strict anaerobic cultures gotten from study participants.  
 
Figure 10:  different means of inhibition zones for all 4 types of cultures as occurred with 
each CHX preparation. 
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5.3 ANOVA tests results:  
To verify whether these differences were statistically significant or not, ANOVA one way 
statistical test was calculated for each of the 4 cultures, whereby it was found that the only 
statistically significant difference (p. value <0.05) between the means of the diameters of 
inhibition zones attained by the different CHX formulations was present in Candida albicans 
cultures as shown in Table 5. 
Table 5: ANOVA one way test results for each type of culture 
Culture type ANOVA result Statistically significant 
Streptococcus mutans 0.073 no 
Candida albicans 0.0001 yes 
Facultative anaerobes 0.867 no 
Strict anaerobes 0.391 no 
 
5.4 Post-hoc analysis: Tukey and Bonferroni tests (C.albicans) 
The only statistically significant difference between all the means of inhibition zones was 
found in the group of C.albicans cultures. Multiple comparisons tests (Tukey and Bonferroni) 
were chosen for post-hoc analysis to measure statistical significance within the group (Tables 
6 & 7). 
Both tests (Tukey and Bonferroni) showed that the 5 CHX formulations could be categorized 
into 2 groups based on the presence or absence of a statistically significant difference 
between the means of inhibition zones for all possible pair combinations. The differences 
between the 2 pure CHX preparations and Corsodyl® were not statistically significant, 
thereby all 3 CHX formulations (pure CHX 0.2%, pure CHX 0.12% and Corsodyl®) were 
considered to be of a comparable antimicrobial efficacy and constituted one group. The 
comparison between Curasept® and Paroex® showed no statistical significance in their 
antimicrobial efficacy against C.albicans, hence both alcohol-free CHX formulations 
constituted a separate group. However, each and every group member showed a statistically 
significant difference when compared to any member of the other group. Accordingly, 
Corsodyl® showed a statistically significant difference (i.e. higher means of diameters of 
inhibition zones) from both Curasept® and Paroex®, which means that its antimicrobial 
efficacy against C.albicans is higher than both preparations. 
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Table 6: Multiple comparisons within C.albicans group by Tukey test 
Type Type Sig. 
1.00 CHX1 CHX2 0.253 
 CHX3 0.970 
 CHX4 0.000 
 CHX5 0.000 
   
2.00 CHX2 CHX1 0.253 
 CHX3 0.614 
 CHX4 0.000 
 CHX5 0.000 
   
3.00 CHX3 CHX1 0.970 
 CHX2 0.614 
 CHX4 0.000 
 CHX5 0.000 
   
4.00 CHX4 CHX1 0.000 
 CHX2 0.000 
 CHX3 0.000 
 CHX5 0.970 
   
5.00 CHX5 CHX1 0.000 
 CHX2 0.000 
 CHX3 0.000 
 CHX4 0.970 
 
 
The result is statistically significant when sig. = 0, highlighted in yellow. 
CHX1: Pure CHX 0.2%  
CHX2: Pure CHX 0.12%  
CHX3: Corsodyl® (0.2% CHX + 5% Alcohol)  
CHX4: Curasept® (0.2% CHX + ADS)  
CHX5: Paroex® (0.12% CHX + 0.05% CPC) 
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Table 7: Multiple Comparisons within C.albicans group by Bonferroni test 
Type Type Sig. 
1.00 CHX1 CHX2 1 
 CHX3 1 
 CHX4 0 
 CHX5 0 
   
2.00 CHX2 CHX1 1 
 CHX3 1 
 CHX4 0 
 CHX5 0 
   
3.00 CHX3 CHX1 1 
 CHX2 1 
 CHX4 0 
 CHX5 0 
   
4.00 CHX4 CHX1 0 
 CHX2 0 
 CHX3 0 
 CHX5 1 
   
5.00 CHX5 CHX1 0 
 CHX2 0 
 CHX3 0 
 CHX4 1 
 
The result is statistically significant when sig. = 0, highlighted in yellow. 
CHX1: Pure CHX 0.2%  
CHX2: Pure CHX 0.12%  
CHX3: Corsodyl® (0.2% CHX + 5% Alcohol)  
CHX4: Curasept® (0.2% CHX + ADS)  
CHX5: Paroex® (0.12% CHX + 0.05% CPC) 
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CHAPTER 6 
DISCUSSION 
 
 
6.1 Introduction: 
In this study, pure cultures prepared from strains available in the laboratory(S. mutans NCTC 
25175 and C. albicans NCTC 36801 type strains), and mixed cultures (facultative and strict 
anaerobes) prepared from oral rinse samples obtained from 14 study participants, were 
utilized to compare the antimicrobial efficacy of 3 different CHX preparations.  
Regarding oral microbial flora specimens taken from study participants, oral rinse samples 
were cultured in such a way that made it possible to differentiate between facultative 
anaerobes and strict anaerobes. These, collectively form dental plaque, the primary 
aetiological agent behind dental caries and periodontal disease. Previous studies have shown 
oral rinse samples to contain a representative sample of all oral microorganisms present, 
including periodontal pathogens found in periodontal pockets (Samaranayake et al., 1986). 
The 3 different CHX formulations under investigation were Corsodyl®, Curasept® and 
Paroex®. Since the 3 products have different CHX concentrations, a positive control (pure 
CHX), was similarly prepared in 2 different concentrations (0.2% and 0.12%).   
6.2 Streptococcus mutans cultures: 
Results indicate that antimicrobial efficacies of all CHX formulations were highest against 
Streptococcus mutans, when compared to other cultures (Figures 9 & 10). This reflects the 
fact that CHX has a potent anti-cariogenic effect that can allow its use as an adjuvant to 
mechanical oral hygiene measures (Emilson, 1977). 
The order of antimicrobial efficacy found for the different CHX formulations in descending 
order was: 
1- Pure CHX 0.2% 
2- Corsodyl® (CHX 0.2% + Alcohol 5%) 
3- Pure CHX 0.12% 
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4- Curasept® (CHX 0.2% + ADS) 
5- Paroex® (CHX 0.12% + CPC 0.05%) 
Corsodyl®, containing 5% alcohol, exhibited a lower means (i.e. lower antimicrobial 
efficacy) than pure CHX 0.2%, but higher than Curasept® which has a similar CHX 
concentration, but is alcohol free. 
The finding that Curasept®, which is alcohol free, scored lower means than pure CHX 0.2%, 
as well as pure CHX 0.12%,  supports the previous findings that additives (such as ADS) 
could decrease the antimicrobial efficacy of CHX (Guggenheim and Meier, 2011). This could 
be due to the strong positive charge of CHX molecule that renders it highly reactive with 
negatively charged molecules, whether they were chemical additives or biological molecules 
in cell membranes (Gomes et al., 2013). 
Even though Paroex® contains 0.05% CPC in its formula, it was surpassed in antimicrobial 
efficacy by pure CHX 0.12%. This can also be attributed to the aforementioned chemical 
interactions between CHX and any additives. However, the addition of 0.05% CPC to the 
formula of Paroex® (0.12% CHX) was possibly the cause of its antimicrobial efficacy being 
comparable to Curasept (0.2% CHX).   
Nevertheless, these results are not conclusive, and should be dealt with cautiously since the 
results of ANOVA test comparing the means of inhibition zones attained by different CHX 
formulations was not statistically significant (p. value = 0.073). Increasing the sample size for 
S.mutans cultures could have decreased the margin of error.  
6.3 C. albicans cultures: 
The means of the inhibition zones’ diameters in all 14 C. albicans cultures were lower than 
recorded for S. mutans cultures, indicating lower susceptibility of C.albicans to all CHX 
formulations under investigation. This is a consistent result when taking into consideration 
the greater complexity of the fungal cell membranes compared to that of Gram positive 
bacteria (Chaffin, 2008).  
 The order of antimicrobial efficacy for the different CHX formulations from highest to 
lowest was: 
1- Pure CHX 0.2% 
2- Corsodyl® (CHX 0.2% + Alcohol 5%) 
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3- Pure CHX 0.12% 
4- Curasept® (CHX 0.2% + ADS) 
5- Paroex® (CHX 0.12% + CPC 0.05%) 
Although this order was similar to that observed in the S. mutans cultures, the differences 
were statistically significant (p. value = 0.0001). Consequently, the interpretation of these 
differences have more credibility than for S. mutans cultures.  
Results clearly indicate that Curasept® and Paroex® are less active than Pure CHX and 
Corsodyl® against C. albicans. This supports a synergistic antimicrobial role for preparations 
containing both alcohol and CHX against Candida. This is further supported by the results of 
the means (Table 4). Even though in all the different types of cultures, pure CHX 0.2% 
always scored a higher means than Corsodyl®, the difference was only marginal for Candida 
albicans cultures (1.30cm for pure CHX 0.2%, 1.29cm for Corsodyl®).  
For both S.mutans and C.albicans, the readings across the 14 cultures were numerically 
closer than in both types of cultures prepared from participants’ oral rinses. Such variability 
reflects the qualitative differences in oral microbial flora from an individual to another.   
6.4 Facultative anaerobic cultures: 
Based on the result of ANOVA test, differences between the antimicrobial efficacies of all 
CHX formulations were found to be statistically insignificant (p. value of 0.867). Therefore, 
all tested CHX formulations have comparable antimicrobial efficacy against facultative 
anaerobic bacteria. According to this finding, it is plausible to assume that all tested CHX 
products might exhibit comparable antimicrobial efficacy in-vivo, where the dental plaque 
more or less matches -qualitatively- this type of culture.  
6.5 Strictly anaerobic cultures: 
No statistically significant difference could be elucidated by comparing the means of 
inhibition zones around the different CHX disks in each of the 14 anaerobic cultures.  
In both groups of oral rinse cultures (facultative and strict anaerobes), obvious differences 
were noted in readings within groups, reflecting the different composition of flora between 
humans. Some individuals might have been harbouring organisms resistant to CHX more 
than others and in rare instances show complete resistance to a particular CHX product. The 
latter case was observed in sample 14 of the strictly anaerobic cultures where disks 
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impregnated with Paroex® were totally devoid of inhibition zones around them. A similar 
picture is seen with antibiotic resistance and maybe attributed to the development of 
resistance to CHX in this study.  
The antimicrobial efficacies of Curasept® and Paroex® were better in both types of mixed 
cultures (i.e. both facultative and strict anaerobic) compared to their scores in pure cultures. It 
was due to this tendency (i.e. to affect mixed cultures more than pure ones) that it was not 
possible to spot a statistically significant difference between the different types of CHX in 
oral rinse cultures. 
The overall sensitivity of oral rinse cultures (facultative and strict anaerobes) was comparable 
to that of pure cultures of C.albicans (Figure 5). Evidently, bacterial colonies become more 
efficient in resisting the effects of antimicrobials with increased compositional complexity 
(Lindhe et al., 2008) 
It is noteworthy to mention that the most commonly resistant strains to all tested CHX 
preparations (growing in distinct colonies inside inhibition zones) were mostly large Gram 
positive cocci. However, it was not possible to rule out whether these strains were oral 
bacteria or acquired contaminants. 
The group that contained pure CHX with its 2 different concentrations (0.2% and 0.12%) and 
Corsodyl®, scored higher overall readings compared to the group of alcohol-free CHX 
formulations (Curasept® and Paroex®).  This was a consistent pattern across all 4 types of 
cultures. Within the first group, Corsodyl® (0.2% CHX) showed higher means than pure 
CHX 0.12% in 3 out of 4 types of cultures (75% of time), while the means for Curasept® 
marginally higher than Paroex® in all 4 types of cultures. 
Herrera et al concluded that CHX formulations that contained alcohol fared better than 
alcohol free CHX formulations (Herrera et al., 2003). In this study, that finding was validated 
with regard to C. albicans cultures. Another in vitro study (Guggenheim and Meier, 2011), 
employing a poly species biofilm, proved that pure or alcohol containing CHX formulations 
exhibit more potent antimicrobial properties than alcohol-free CHX preparations containing 
ADS as a chemical additive. 
A common adverse effect of alcohol is its carcinogenic potential. These adverse effects are 
not expected to occur with concentrations below 25%, and are found to occur only when used 
on a daily basis for prolonged periods of time (Winn et al., 1991). The design of CHX 
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formulations that avoid the common side effects of the compound without affecting its 
antimicrobial efficacy remains to be a noble but elusive goal. For the while, patient risk 
benefit ratio should be evaluated when its use is indicated for a few days (Guggenheim and 
Meiers, 2011). 
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CHAPTER 7 
LIMITATIONS 
 
 
There are some important limitations to the present study: 
 Organisms suspended in oral rinse samples are in a planktonic state and do not 
exhibit the characteristics of the typical plaque biofilm. Dental plaque biofilms are 
expected to exhibit increased antimicrobial resistance (Lindhe et al., 2008). 
Previous studies used plaque biofilm models that needed complicated methods of 
preparations (Guggenheim and Meier, 2011 & Herrera et al., 2003). 
 Mixed cultures (facultative and strict anaerobes) were dealt with collectively. The 
sensitivity of isolated oral bacterial species to CHX was not investigated since it 
was beyond the scope of this study. 
 The study sample size was limited. 
 Extrapolation of the current results to what is expected to occur in oral 
environments needs a complementary in-vivo clinical study. 
 Even though a digital calliper was used to measure the diameters of inhibition 
zones, determining the boundaries of inhibition zones proved to be difficult and 
subjective at times.  
 The presence of contaminant bacterial species could never be ruled out. 
 The presence of non-albicans species of Candida (e.g. C.tropicalis, 
C.parapsilosis, C.glabrata and C.krusei) in oral rinse samples was not 
investigated. The role these species might play in conferring resistance of 
C.albicans to CHX should be investigated on a molecular level.  
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CHAPTER 8 
CONCLUSIONS 
 
 
 CHX formulations that contain alcohol (Corsodyl® in this study) are more potent 
against C.albicans than alcohol-free CHX formulations (Curasept® and 
Paroex®). 
 Despite the difference in concentrations, Curasept® (0.2% CHX) and Paroex® 
(0.12% CHX) have similar antimicrobial efficacies. The addition of 0.05% CPC in 
Paroex®, or ADS in Curasept®, may support these results. 
 Chemical Additives seem to negatively affect the antimicrobial efficacy of all 
CHX formulations, when compared to the corresponding concentration of pure 
CHX (only applicable in C.albicans cultures). 
 In mixed cultures (facultative and strict anaerobes), alcohol-free CHX 
formulations (Curasept® and Paroex®) have antimicrobial efficacies comparable 
to that of both alcohol-containing (Corsodyl®) and pure CHX formulations (0.2% 
and 0.12%). 
 Cultures prepared from human oral rinse samples demonstrated inter-individual 
variations in sensitivity to CHX formulations, i.e. the magnitude of antimicrobial 
activity of CHX differs from one oral flora to another, and is not universal. 
 S.mutans cultures were sensitive to all CHX formulations more than other types of 
cultures (Figure 6), which translates into potent anticariogenic properties 
possessed by all formulations of CHX. 
 C.albicans is more resistant/less sensitive to all CHX formulations than S.mutans.  
 CHX formulations that contain alcohol should be reserved for Candidal 
infections. However, the minimum effective dose of alcohol in CHX formulations 
needs to be determined by further investigations. 
 Since S.mutans is a primary colonizer, the anti-cariogenic effect of CHX is 
expected to be enhanced if applied immediately after tooth brushing. 
 Curasept® (0.2% CHX) can be prescribed in a regimen similar to Paroex® 
(0.12% CHX), i.e. for prophylactic, long term use. 
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 The pattern of inter-individual variations in the antimicrobial efficacy of CHX 
parallels the pattern observed in antibiotic sensitivity tests. This might herald the 
occurrence of resistant strains to CHX. Further studies are needed in this regard. 
 Manufacturers should acknowledge the fact that any chemical additive can 
potentially decrease the antimicrobial efficacy of CHX. 
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Appendix 1 
Information Sheet 
The antimicrobial efficacy of 3 chlorhexidine mouth rinses: an in-vitro analysis 
 
I am Dr.BM Abdalrahman, a postgraduate dental student at the faculty of Dentistry, 
University of Western Cape. 
I would like to invite you to take part in a research study. Before you decide, you need to 
understand why the research is being done and what it would involve for you. Please take 
time to read the following information carefully. Ask questions if anything you read is not 
clear or would like more information. Take time to decide whether or not to take part. 
What is the purpose of the study? 
This study is aiming to measure -in a laboratory setting- the antimicrobial effects of 
3different chlorhexidine mouth washes. These mouthwashes are available in local markets 
and have been marketed as being effective in inhibiting oral bacteria to more or less similar 
degrees. 
Why have I been invited? 
You have been invited to participate in this research because you satisfy the inclusion criteria 
of the study, which states that individuals who are dentate (have the full set of teeth) or 
partially dentate, above 12 years of age and systemically healthy are eligible to participate. 
Sampling of participants is meant to be random, i.e. no specific ethnic group or gender is 
targeted more than the rest of the population. If you are a smoker, diabetic, pregnant, have 
other medical/genetic conditions (as will be explained by the examiner), under antibiotic 
treatment at the moment or during the past three months, or you have no natural teeth left, 
then you are unsuitable to participate in this study (but anyway, thanks for your time!). 
Do I have to take part? 
It is up to you to decide. We will describe the study and go through the information sheet, 
which we will give to you. We will then ask you to sign a consent form to show you agreed 
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to take part. You are free to withdraw at any time, without giving a reason (this will not affect 
the standard of care you receive). 
What will happen to me if I take part? 
10 ml of sterile normal phosphate buffered saline will be offered to you to rinse your mouth 
with. You are expected to rinse for 60 seconds in the presence of the researcher. This 
procedure is totally painless and no bleeding or tissue damage will ensue afterwards. 
Collected oral rinse samples will then be sent for microbiological study in the laboratory to 
culture different bacteria that are commonly found in the mouth. You will be referred to the 
appropriate department within our faculty in case any dental or oral disease that needs 
treatment is detected. 
Participating in this study will cost you nothing; in fact it might save you money by the early 
detection of any dental or oral lesions which makes treatment easier and cheaper. 
What will I have to do? 
 For the purposes of this study, nothing more is required from you. However, regular visits to 
the dentist in addition to sustained efforts to clean your teeth (by brushing and flossing) will 
always be encouraged if you want to stay healthy and keep your teeth in good shape. 
What are the possible disadvantages and risks of taking part? 
No perceived disadvantages or risks are expected to result from taking part in this study. 
What are the possible benefits of taking part? 
We cannot promise the study will help you, but the information we get from the study will 
help to increase the understanding of the microbiology of oral fungal infections, gum disease 
and dental caries. 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researcher who will do his best to answer your questions (contact number: 0798632238).  
If you remain unhappy and wish to complain formally, you can do this through Professor 
LXG Stephen, diagnostic cluster chairperson, Faculty of Dentistry, University of Western 
Cape. 
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Will my taking part in the study be kept confidential? 
All information which is collected about you during the course of the research will be kept 
strictly confidential, and any information about you which leaves the hospital will have your 
name and address removed so that you cannot be recognized.  
How your data will be collected? 
Samples collected from you as a participant will be given a code known only to the 
researcher before being sent for laboratory examination. A master list identifying participants 
to the research codes data will be held on a password protected computer accessed only by 
the researcher. Hard paper will be stored in a locked cabinet, within locked office, accessed 
only by the researcher. Electronic data will be stored on a password protected computer 
known only by the researcher. Your data will be accessible only to authorized persons such as 
researchers within the team, supervisors, sponsors and for monitoring the quality, regulatory 
authorities /R&D audit. Your data will be retained for a period of 3 years before it will be 
disposed of securely. 
What will happen if I don’t carry on with the study? 
If you withdraw from the study we will destroy all your identifiable samples, but we will 
need to use the data collected up to your withdrawal.  
What will happen to the results of the research study? 
The results of this research study will be submitted as a thesis for a master degree, and if the 
degree is approved by the university senate, I intend to publish these results in dental research 
journals. These results can be made available to you by sending it via e-mails if you wish to 
be notified by the outcome of the study.  We confirm again that you will not be identified in 
any report/publication unless you have given your personal consent. 
Who is organizing or sponsoring the research? 
The University of the Western Cape represented by two departments –the Department of Oral 
Medicine and Periodontics, and the Department of Medical Biosciences- will be organizing 
and sponsoring this research project. 
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Further information and contact details: 
1. General information can be found at medical research websites like www.pubmed.gov 
or www.cdc.gov  
2. For specific information about this research project, you are welcome to contact me at 
this e-mail address 3115947@uwc.ac.za  
This study has been ethically reviewed and approved by the UWC Senate Biomedical 
Research Ethics Committee (approval number_____). 
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Appendix 2 
 
Informed Consent 
 
I,  (Name…………………………….) have been informed about the study entitled the 
antimicrobial efficacy of 3 chlorhexidine mouth rinses: an in-vitro analysis, by 
Dr.BasheerAbdalrahman. 
I understand the purpose and procedures of the study. 
I have been given an opportunity to ask questions about the study and have had answers to 
my satisfaction. 
I declare that my participation in this study is entirely voluntary and that I may withdraw at 
any time without affecting any treatment or care that I would usually be entitled to. 
If I have any further questions/concerns or queries related to the study I understand that I may 
contact the researcher at cell phone number 0798632238 or via e-mail 3115947@uwc.ac.za 
If I have any questions or concerns about my rights as a study participant, or if I am 
concerned about an aspect of the study or the researchers then I may contact:  
DENTISTRY RESEARCH ETHICS COMMMITTEE 
Research Office, Tygerberg Campus 
Francie van Zyl Drive 
Private Bag X1  
Tygerberg 
7505 
Cape Town, SOUTH AFRICA 
Tel: 27 21 937 3095 - Fax: 27 21 931 2287 
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Email: suenaidoo@uwc.ac.za 
____________________      ____________________ 
Signature of Participant                            Date 
 
 
____________________   _____________________ 
Signature of Witness                                Date 
(Where applicable)      
____________________   _____________________ 
Signature of Translator                            Date 
(Where applicable) 
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Appendix 3 
Data Capturing Tables 
 
Table (A): Readings from oral rinse cultures  
*FCLT: Facultative aerobic culture, AnO2: Strictly Anaerobic culture. 
** CHX1: Pure CHX 0.2%, CHX2: Pure CHX 0.12%, CHX3: Corsodyl, CHX4: Curasept, CHX5: Paroex 
 
 Oral rinse 
1 
Oral rinse 
2 
Oral rinse 
3 
Oral rinse 
4 
Oral rinse 
5 
Oral rinse 
6 
Oral rinse 
7 
 FCLT AnO2 FCLT AnO2 FCLT AnO2 FCLT AnO2 FCLT AnO2 FCLT AnO2 FCLT AnO2 
CHX1               
               
               
CHX2               
               
               
CHX3               
               
               
CHX4               
               
               
CHX5               
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Table (B): Readings from pure Streptococcus mutans cultures 
* CHX1: Pure CHX 0.2%, CHX2: Pure CHX 0.12%, CHX3: Corsodyl, CHX4: Curasept, CHX5: Paroex 
 S. mutans 
1 
S. mutans 
2 
S. mutans 
3 
S. mutans 
4 
S. mutans 
5 
S. mutans 
6 
S. mutans 
7 
CHX1        
        
        
CHX2        
        
        
CHX3        
        
        
CHX4        
        
        
CHX5        
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Table (C): Readings from pure Candida albicans cultures 
* CHX1: Pure CHX 0.2%, CHX2: Pure CHX 0.12%, CHX3: Corsodyl, CHX4: Curasept, CHX5: Paroex 
 C. albicans 
1 
C. albicans 
2 
C. albicans 
3 
C. albicans 
4 
C. albicans 
5 
C. albicans 
6 
C. albicans 
7 
CHX1        
        
        
CHX2        
        
        
CHX3        
        
        
CHX4        
        
        
CHX5        
        
        
 
 
 
 
 
 
 
